[Advances in the study of glucokinase and small molecule glucokinase activators].
Li
Yong-Qiang
YQ
School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Feng
Zhi-Qiang
ZQ
Song
Hong-Rui
HR
Guo
Yan-Sen
YS
Guo
Zong-Ru
ZR
D000818:Animals; D001665:Binding Sites; D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D004789:Enzyme Activation / Q000187:drug effects; D020536:Enzyme Activators / Q000737:chemistry / Q000494:pharmacology*; D005941:Glucokinase / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000494:pharmacology; D008968:Molecular Conformation; D010766:Phosphorylation / Q000187:drug effects; D013450:Sulfones / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology
C503863:2-cyclohexyl-1-(4-methanesulfonylphenyl)cyclopropanecarboxylic acid thiazol-2-ylamide; D001786:Blood Glucose; D020536:Enzyme Activators; D007004:Hypoglycemic Agents; C476008:RO-28-0450; D013450:Sulfones; D013844:Thiazoles; D005941:Glucokinase